Website The British Pharmacopoeia ( BP) is the national of the. It is an annually published collection of quality standards for UK substances. It is used by individuals and involved in,,. Pharmacopoeial standards are publicly available and legally enforceable standards of quality for medicinal products and their constituents. PDF| Pharmacopoeias have been an important feature of medicine for centuries. They have served to codify pharmaceutical and therapeutic knowledge,. Welcome to the British Pharmacopoeia. About us| Buy the BP 2019| Access your subscription| Order BPCRS| Help & assistance. Welcome to the British. Feb 14, 2013 British Pharmacopoeia 2013: Mixed media product: TSO: 321:: 31 Aug 2012: The British Pharmacopoeia (BP) 2012 is the official collection of standards for UK medicinal products and pharmaceutical substances. The British Pharmacopoeia is an important statutory component in the control of medicines which complements and assists the licensing and inspection processes of the (MHRA) of the United Kingdom. Together with the (BNF), the British Pharmacopoeia defines the UK's pharmaceutical standards. Pharmacopoeial standards are compliance requirements; that is, they provide the means for an independent judgement as to the overall quality of an article, and apply throughout the shelf-life of a product. Inclusion of a substance in a pharmacopoeia does not indicate that it is either safe or effective for the treatment of any disease. Contents • • • • • • • • • • Legal basis [ ] The British Pharmacopoeia is published on behalf of the; on the recommendation of the, in accordance with section 99(6) of the, and notified in draft to the (EC) in accordance with. The of the (as amended by Supplements published by the ) are reproduced either in the British Pharmacopoeia, or in the associated edition of the British Pharmacopoeia (Veterinary). In the pharmacopoeia, certain drugs and preparations are included regardless of the existence of actual or potential. Where substances are protected by, their inclusion in the pharmacopoeia neither conveys, nor implies, license to manufacture. History [ ] The regulation of medicinal products by officials in the United Kingdom dates back to the reign of (1491–1547). The of London had the power to inspect products in the London area, and to destroy defective stock. The first list of approved drugs, with information on how they should be prepared, was the London Pharmacopoeia, published in 1618. The first edition of what is now known as the British Pharmacopoeia was published in 1864, and was one of the first attempts to harmonise pharmaceutical standards, through the merger of the London, Edinburgh and Dublin Pharmacopoeias. The name that had some currency at the time was Pharmacopoeia Britannica (Ph. A commission was first appointed by the (GMC), when the body was made statutorily responsible under the for producing a British pharmacopoeia on a national basis. In 1907, the British Pharmacopoeia was supplemented by the, which gave information on drugs and other pharmaceutical substances not included in the BP, and provided standards for these. The established the legal status of the British Pharmacopoeia Commission, and of the British Pharmacopoeia, as the UK standard for medicinal products under section 4 of the Act. The British Pharmacopoeia Commission continues the work of the earlier Commissions appointed by the GMC, and is responsible for preparing new editions of the British Pharmacopoeia and the British Pharmacopoeia (Veterinary), and for keeping them up to date. Under Section 100 of the Medicines Act, the British Pharmacopoeia Commission is also responsible for selecting and devising (BANs )(see ). Since its first publication back in 1864, the distribution of the British Pharmacopoeia has grown throughout the world. It is now used in over 100 countries. Australia and Canada are two of the countries that have adopted the BP as their national standard alongside the UK; in other countries, e.g., the BP is recognised as an acceptable reference standard. Content [ ] The current edition of the British Pharmacopoeia comprises six volumes, which contain nearly 3,000 monographs for drug substances,, and formulated preparation, together with supporting general notices, appendices (test methods, etc.), and reference spectra, used in the practice of, all comprehensively indexed and cross-referenced for easy reference. Items used exclusively in in the UK are included in the BP (Veterinary). Main article: (BANs) are devised or selected by the British Pharmacopoeia Commission (BPC), and published by the Health Ministers, on the recommendation of the Commission on Human Medicines, to provide a list of names of substances or articles referred to in Section 100 of the. BANs are short, distinctive names, for substances; where the systematic chemical or other scientific names are too complex for convenient general use. As a consequence of, as amended, the British Approved Names, since 2002, may be assumed to be the (rINN), except where otherwise stated. Descargar libro el campo de batalla de la mente pdf to excel converter. A (WHO) identifies a pharmaceutical substance or active pharmaceutical ingredient by a unique name that is globally recognised, and in which no party can claim any proprietary rights.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |